Majid M. Alshamrani
-
- Antibiotic Use and Resistance 12
- Molecular Medicine top 5%
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies 7
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 6
- Infection Control in Healthcare 6
-
- Nosocomial Infections in ICU 8
-
- Central Venous Catheters and Hemodialysis 7
-
- Sepsis Diagnosis and Treatment 6
- Co-authors
- Aiman El‐SaedHanan H. BalkhyAsim AlsaediThamer H. AlenaziFayssal FarahatYaseen M. ArabiHail M. Al-AbdelyAbdulaziz Bin Saeed
- Journals
- SHILAP Revista de lepidopterología (1 paper)Clinical Infectious Diseases (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- Saudi ArabiaEgyptUnited Kingdom
In The Last Decade
Majid M. Alshamrani
41 papers receiving 591 citations
Peers
Comparison fields: 5 of 87
- Applied Microbiology and Biotechnology 180
- Molecular Medicine 114
- Modeling and Simulation 71
- Infectious Diseases 251
- Critical Care and Intensive Care Medicine 70
Countries citing papers authored by Majid M. Alshamrani
This map shows the geographic impact of Majid M. Alshamrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majid M. Alshamrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majid M. Alshamrani more than expected).
Fields of papers citing papers by Majid M. Alshamrani
This network shows the impact of papers produced by Majid M. Alshamrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majid M. Alshamrani. The network helps show where Majid M. Alshamrani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Majid M. Alshamrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 113 | |
| 13 | 2021 | 28 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 14 | |
| 18 | 2020 | 26 | |
| 19 | 2019 | 18 | |
| 20 | 2018 | 4 |
About Majid M. Alshamrani
Majid M. Alshamrani is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Modeling and Simulation, having authored 46 papers that have together received 604 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (12 papers), COVID-19 Clinical Research Studies (9 papers), Nosocomial Infections in ICU (8 papers), COVID-19 epidemiological studies (7 papers), Central Venous Catheters and Hemodialysis (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Infection Control in Healthcare (6 papers) and Sepsis Diagnosis and Treatment (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (180 citations), Molecular Medicine (114 citations) and Modeling and Simulation (71 citations). Majid M. Alshamrani has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Aiman El‐Saed, Hanan H. Balkhy, Asim Alsaedi, Thamer H. Alenazi, Fayssal Farahat, Yaseen M. Arabi, Hail M. Al-Abdely, Abdulaziz Bin Saeed, Abdullah M. Assiri and Sameera M. Al Johani. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.